covid19

Konica Minolta Research Reveals Impact of COVID-19 on SMBs Pain Points Study Reveals Depth of Security and Remote Work Challenges During Pandemic Ramsey, NJ - Konica Minolta Business Solutions U.S.A., Inc. (Konica Minolta) is pleased to share findings revealed in new research by Keypoint Intelligence, “Top SMB IT Pain Points & Solutions.” Created on behalf of Konica Minolta, … [Read more...] about Impact of COVID-19 on SMBs

U.S. government to purchase at not-for-profit price 200 million doses in 2021 and 300 million in the first half of 2022 Doses to be donated to approximately 100 low- and lower middle-income countries including those in the African Union via the COVAX Facility Effort is part of the companies’ recent pledge of two billion doses to ensure global equitable access to the … [Read more...] about Pfizer and BioNTech to Provide 500 Million Doses of COVID-19 Vaccine to U.S. Government for Donation to Poorest Nations

A rare blood clotting condition has occurred in some people after receiving the AstraZeneca COVID-19 vaccine. If the new research is correct, it could mean that blood clots could be easily treated. — Read on www.npr.org/sections/coronavirus-live-updates/2021/03/21/979781065/european-scientists-zero-in-on-astrazeneca-blood-clot-link … [Read more...] about European Scientists Zero In On AstraZeneca COVID-19 Vaccine Blood Clot Link : Coronavirus Updates : NPR

Pfizer and BioNTech SE today announced an advance purchase agreement with COVAX for up to 40 million doses of the Pfizer-BioNTech COVID-19 Vaccine. The doses will be delivered throughout 2021. COVAX is a global initiative coordinated by the Global Alliance for Vaccines and Immunization (GAVI), the Coalition for Epidemic Preparedness Innovations (CEPI) and the World Health … [Read more...] about Pfizer and BioNTech Reach Agreement with COVAX for Advance Purchase of Vaccine to Help Combat COVID-19

The first UK clinical trials of a nasal spray proven to kill 99.9% of the coronavirus that causes Covid-19 will begin on January 11th at Ashford and St Peter’s Hospitals NHS Foundation Trust, in Surrey. SaNOtize Nitric Oxide Nasal Spray (NONS) kills 99.9% of coronavirus in lab tests Nasal spray blocks viral entry into the body, destroys virus and prevents it from … [Read more...] about Covid-busting Nasal Spray Begins UK Trials January 11th

Action Follows Thorough Evaluation of Available Safety, Effectiveness, and Manufacturing Quality Information by FDA Career Scientists, Input from Independent Experts Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the second vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome … [Read more...] about FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 Vaccine

Spending on Cloud Services is Bright Spot in 2020 IT Spending Outlook Worldwide IT spending is projected to total $3.4 trillion in 2020, a decline of 8% from 2019, according to the latest forecast by Gartner, Inc. The coronavirus pandemic and effects of the global economic recession are causing CIOs to prioritize spending on technology and services that are deemed … [Read more...] about Gartner Says Global IT Spending to Decline 8% in 2020 Due to Impact of COVID-19

Nassim Taleb got this right, UK and Swedish Governments did not - avoiding lockdown and losing precious time to contain pandemic just brought unnecessary thousands of deaths. Kudos to governments of Israel and Greece embracing early lockdown measures and choosing lives over doubtful models. Prioritizing local economy in the time of the global crisis is a futile exercise … [Read more...] about Herd Immunity as a Government Policy in Response to COVID-19 Failed Miserably